Bone Biologics Corp. (BBLGW) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bone Biologics Corp. (BBLGW:NASDAQ), powered by AI.
- Current Price
- $15.34
- Sector
- Healthcare
What is the Bone Biologics Corp. stock price forecast?
Bone Biologics Corp. is currently trading at $15.34. View real-time AI analysis on Alpha Lenz.
What is Bone Biologics Corp. insider trading activity?
View the latest insider trading data for Bone Biologics Corp. on Alpha Lenz.
What is Bone Biologics Corp.'s P/E ratio?
View Bone Biologics Corp.'s valuation metrics on Alpha Lenz.
Bone Biologics Corp.
NASDAQ · BBLGW“Bone Biologics Corp.'s ROE is -70.2%. Explore profitability and growth together.”
Ask for details →Company Overview
Bone Biologics Corp. operates in the biotechnology sector, focusing on products that enhance bone growth and regeneration. The company's primary aim is to develop and commercialize NELL-1, a proprietary protein that has shown potential in accelerating bone repair and treating spinal fusion. Bone Biologics targets medical conditions requiring bone regeneration, such as spinal disorders, osteoporosis, and other orthopedic and neurosurgical needs. The innovations by Bone Biologics are poised to influence both the healthcare and biotechnology industries by offering alternatives to existing bone graft solutions. As Bone Biologics continues its research and development efforts, it aims to address critical gaps in surgical outcomes with products that enhance patient recovery.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Bone Biologics Corp.'s ROE is -70.2%. Explore profitability and growth together.”
Ask for details →Frequently Asked Questions
Bone Biologics Corp. (ticker: BBLGW) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 2 employees.
The current price is $15.34 with a P/E ratio of -x and P/B of -x.
ROE is -70.17%.